{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:33:53Z","timestamp":1792715633954,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12022-018-9527-6","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:19:33Z","timestamp":1524136773000},"page":"113-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["Immunohistochemistry in Diagnostic Parathyroid Pathology"],"prefix":"10.1007","volume":"29","author":[{"given":"Lori A.","family":"Erickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,7]]},"reference":[{"key":"9527_CR1","unstructured":"Rosai J, D.R., Carcangiu ML, Frable WJ, Tallini G, Tumors of the thyroid and parathyroid glands. AFIP Atlas of Tumor Pathology, ed. S. SG. Vol. Fascicle 21. 2014, Silver Spring, Maryland, USA: ARP Press. 606."},{"issue":"2","key":"9527_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF02739826","volume":"10","author":"T Tomita","year":"1999","unstructured":"Tomita, T., Immunocytochemical staining patterns for parathyroid hormone and chromogranin in parathyroid hyperplasia, adenoma, and carcinoma. Endocr Pathol, 1999. 10(2): p. 145\u2013156.","journal-title":"Endocr Pathol"},{"issue":"3","key":"9527_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/00000478-200203000-00008","volume":"26","author":"LA Erickson","year":"2002","unstructured":"Erickson, L.A., Jin L., Papotti M., Lloyd R.V., Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol, 2002. 26(3): p. 344\u2013349.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9527_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12022-013-9258-7","volume":"25","author":"H Gucer","year":"2014","unstructured":"Gucer, H. and O. Mete, Endobronchial gangliocytic paraganglioma: not all keratin-positive endobronchial neuroendocrine neoplasms are pulmonary carcinoids. Endocr Pathol, 2014. 25(3): p. 356\u2013358.","journal-title":"Endocr Pathol"},{"issue":"5","key":"9527_CR5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2169\/internalmedicine1962.28.640","volume":"28","author":"T Maeda","year":"1989","unstructured":"Maeda, T., et al., A case of calcitonin-producing parathyroid adenoma with primary hyperparathyroidism. Jpn J Med, 1989. 28(5): p. 640\u2013646.","journal-title":"Jpn J Med"},{"issue":"4","key":"9527_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5858\/2005-129-531-SCCOTO","volume":"129","author":"L Chen","year":"2005","unstructured":"Chen, L., T.A. Dinh, and A. Haque, Small cell carcinoma of the ovary with hypercalcemia and ectopic parathyroid hormone production. Arch Pathol Lab Med, 2005. 129(4): p. 531\u2013533.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"9527_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/00003072-197810000-00003","volume":"3","author":"BR Williamson","year":"1978","unstructured":"Williamson, B.R., et al., Poorly differentiated lymphocytic lymphoma with ectopic parathormone production: visulization of metastatic calcification by bone scan. Clin Nucl Med, 1978. 3(10): p. 382\u2013384.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"9527_CR8","first-page":"483","volume":"54","author":"G Holtz","year":"1979","unstructured":"Holtz, G., T.R. Johnson, Jr., and M.E. Schrock, Paraneoplastic hypercalcemia in ovarian tumors. Obstet Gynecol, 1979. 54(4): p. 483\u2013487.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"9527_CR9","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1002\/1097-0142(19800515)45:10<2652::AID-CNCR2820451027>3.0.CO;2-0","volume":"45","author":"RS Goldberg","year":"1980","unstructured":"Goldberg, R.S., D.B. Pilcher, and J.W. Yates, The aggressive surgical management of hypercalcemia due to ectopic parathormone production. Cancer, 1980. 45(10): p. 2652\u20132654.","journal-title":"Cancer"},{"issue":"3","key":"9527_CR10","first-page":"411","volume":"150","author":"MH Max","year":"1980","unstructured":"Max, M.H. and P.H. Lawrence, Ectopic secretion of parathyroid hormone. Surg Gynecol Obstet, 1980. 150(3): p. 411\u2013418.","journal-title":"Surg Gynecol Obstet"},{"issue":"6","key":"9527_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0090-4295(85)90297-3","volume":"25","author":"S Patel","year":"1985","unstructured":"Patel, S. and J.T. Rosenthal, Hypercalcemia in carcinoma of prostate. Its cure by orchiectomy. Urology, 1985. 25(6): p. 627\u2013629.","journal-title":"Urology"},{"issue":"1","key":"9527_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0090-8258(91)90095-M","volume":"40","author":"R Buller","year":"1991","unstructured":"Buller, R., Taylor K., Burg A.C., Berman M.L., DiSaia P.J., Paraneoplastic hypercalcemia associated with adenosquamous carcinoma of the endometrium. Gynecol Oncol, 1991. 40(1): p. 95\u201398.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"9527_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1507\/endocrj.EJ12-0406","volume":"60","author":"K Nakajima","year":"2013","unstructured":"Nakajima, K., Tamai M., Okaniwa S., Nakamura Y., Kobayashi M., Niwa T., Horigome N., Ito N., Suzuki S., Nishio S., Komatsu M., Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature. Endocr J, 2013. 60(5): p. 557\u2013562.","journal-title":"Endocr J"},{"issue":"2","key":"9527_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s002619900463","volume":"24","author":"Y Koyama","year":"1999","unstructured":"Koyama, Y., Ishijima H., Ishibashi A., Katsuya T., Ishizaka H., Aoki J., Endo K., Intact PTH-producing hepatocellular carcinoma treated by transcatheter arterial embolization. Abdom Imaging, 1999. 24(2): p. 144\u2013146.","journal-title":"Abdom Imaging"},{"issue":"6","key":"9527_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00000478-200106000-00015","volume":"25","author":"AM Oliveira","year":"2001","unstructured":"Oliveira, A.M., Tazelaar H.D., Myers J.L., Erickson L.A., Lloyd R.V., Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol, 2001. 25(6): p. 815\u2013819.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9527_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/modpathol.3880044","volume":"13","author":"SN Agoff","year":"2000","unstructured":"Agoff, S.N., Lamps L.W., Philip A.T., Amin M.B., Schmidt R.A., True L.D., Folpe A.L., Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol, 2000. 13(3): p. 238\u2013242.","journal-title":"Mod Pathol"},{"issue":"1","key":"9527_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1365-2559.2000.00801.x","volume":"36","author":"O Kaufmann","year":"2000","unstructured":"Kaufmann, O. and M. Dietel, Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology, 2000. 36(1): p. 8\u201316.","journal-title":"Histopathology"},{"issue":"1","key":"9527_CR18","first-page":"5","volume":"12","author":"AL Folpe","year":"1999","unstructured":"Folpe, A.L., Gown A.M., Lamps L.W., Garcia R., Dail D.H., Zarbo R.J., Schmidt R.A., Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol, 1999. 12(1): p. 5\u20138.","journal-title":"Mod Pathol"},{"issue":"3","key":"9527_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/0959-8049(95)00560-9","volume":"32A","author":"D Fabbro","year":"1996","unstructured":"Fabbro, D., di Loreto C., Stamerra O., Beltrami C.A., Lonigro R., Damante G., TTF-1 gene expression in human lung tumours. Eur J Cancer, 1996. 32A(3): p. 512\u2013517.","journal-title":"Eur J Cancer"},{"issue":"3","key":"9527_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/PAS.0b013e318185d21b","volume":"33","author":"M Bisceglia","year":"2009","unstructured":"Bisceglia, M., Ragazzi M., Galliani C.A., Lastilla G., Rosai J., TTF-1 expression in nephroblastoma. Am J Surg Pathol, 2009. 33(3): p. 454\u2013461.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9527_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/modpathol.3801002","volume":"21","author":"D Nonaka","year":"2008","unstructured":"Nonaka, D., Tang Y., Chiriboga L., Rivera M., Ghossein R., Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms. Mod Pathol, 2008. 21(2): p. 192\u2013200.","journal-title":"Mod Pathol"},{"issue":"6","key":"9527_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1365-2559.2006.02365.x","volume":"48","author":"AD Graham","year":"2006","unstructured":"Graham, A.D., A.R. Williams, and D.M. Salter, TTF-1 expression in primary ovarian epithelial neoplasia. Histopathology, 2006. 48(6): p. 764\u2013765.","journal-title":"Histopathology"},{"key":"9527_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5414\/NP301047","volume":"36","author":"D Pratt","year":"2017","unstructured":"Pratt, D., Afsar N., Allgauer M., Fetsch P., Palisoc M., Pittaluga S., Quezado M., Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clonedependent and associated with tumor location. Clin Neuropathol, 2017, 36, 263, 271.","journal-title":"Clin Neuropathol"},{"issue":"4","key":"9527_CR24","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/his.12287","volume":"64","author":"YB Ni","year":"2014","unstructured":"Ni, Y.B., Tsang J.Y.S., Shao M.M., Chan S.K., Tong J., To K.F., Tse G.M., TTF-1 expression in breast carcinoma: an unusual but real phenomenon. Histopathology, 2014. 64(4): p. 504\u2013511.","journal-title":"Histopathology"},{"issue":"4","key":"9527_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00292-010-1414-y","volume":"32","author":"HG Reis","year":"2011","unstructured":"Reis, H.G., et al., [TTF-1 (8G7G3\/1) positive colon adenocarcinoma: diagnostic implications]. Pathologe, 2011. 32(4): p. 349\u2013351.","journal-title":"Pathologe"},{"key":"9527_CR26","unstructured":"Hakim, S.A. and N.S. Youssef, Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters. Appl Immunohistochem Mol Morphol, 2015."},{"issue":"2","key":"9527_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/PAI.0b013e3181bdf4e7","volume":"18","author":"A Matoso","year":"2010","unstructured":"Matoso, A., Singh K., Jacob R., Greaves W.O., Tavares R., Noble L., Resnick M.B., DeLellis R.A., Wang L.J., Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl Immunohistochem Mol Morphol, 2010. 18(2): p. 142\u2013149.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"11","key":"9527_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.prp.2011.08.009","volume":"207","author":"M Dettmer","year":"2011","unstructured":"Dettmer, M., Kim T.E., Jung C.K., Jung E.S., Lee K.Y., Kang C.S., Thyroid transcription factor-1 expression in colorectal adenocarcinomas. Pathol Res Pract, 2011. 207(11): p. 686\u2013690.","journal-title":"Pathol Res Pract"},{"issue":"3","key":"9527_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1385\/EP:15:3:247","volume":"15","author":"LA Erickson","year":"2004","unstructured":"Erickson, L.A., Papouchado B., Dimashkieh H., Zhang S., Nakamura N., Lloyd R.V., Cdx2 as a marker for neuroendocrine tumors of unknown primary sites. Endocr Pathol, 2004. 15(3): p. 247\u2013252.","journal-title":"Endocr Pathol"},{"key":"9527_CR30","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.biopha.2017.05.028","volume":"92","author":"E Marchiori","year":"2017","unstructured":"Marchiori, E., Pelizzo M.R., Herten M., Townsend D.M., Rubello D., Boschin I.M., Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene. Biomed Pharmacother, 2017. 92: p. 843\u2013848.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"9527_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PAS.0b013e31820371e4","volume":"35","author":"D Nonaka","year":"2011","unstructured":"Nonaka, D., Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions. Am J Surg Pathol, 2011. 35(1): p. 145\u2013151.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"9527_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","volume":"99","author":"B Guan","year":"2016","unstructured":"Guan, B., Welch J.M., Sapp J.C., Ling H., Li Y., Johnston J.J., Kebebew E., Biesecker L.G., Simonds W.F., Marx S.J., Agarwal S.K., GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism. Am J Hum Genet, 2016. 99(5): p. 1034\u20131044.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"9527_CR33","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","volume":"35","author":"AR Laury","year":"2011","unstructured":"Laury, A.R., Perets R., Piao H., Krane J.F., Barletta J.A., French C., Chirieac L.R., Lis R., Loda M., Hornick J.L., Drapkin R., Hirsch M.S., A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol, 2011. 35(6): p. 816\u2013826.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"9527_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/modpathol.2011.3","volume":"24","author":"A Ozcan","year":"2011","unstructured":"Ozcan, A., Shen S.S., Hamilton C., Anjana K., Coffey D., Krishnan B., Truong L.D., PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol, 2011. 24(6): p. 751\u2013764.","journal-title":"Mod Pathol"},{"issue":"3","key":"9527_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/01.pai.0000213144.70148.8e","volume":"15","author":"N Bakshi","year":"2007","unstructured":"Bakshi, N., Kunju L.P., Giordano T., Shah R.B., Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic Implications. Appl Immunohistochem Mol Morphol, 2007. 15(3): p. 310\u2013315.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"9527_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2015.04.018","volume":"411","author":"SI Han","year":"2015","unstructured":"Han, S.I., Y. Tsunekage, and K. Kataoka, Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1. Mol Cell Endocrinol, 2015. 411: p. 113\u2013120.","journal-title":"Mol Cell Endocrinol"},{"key":"9527_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.2011.06221.x","volume":"1237","author":"IV Grigorieva","year":"2011","unstructured":"Grigorieva, I.V. and R.V. Thakker, Transcription factors in parathyroid development: lessons from hypoparathyroid disorders. Ann N Y Acad Sci, 2011. 1237: p. 24\u201338.","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"9527_CR38","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI42021","volume":"120","author":"IV Grigorieva","year":"2010","unstructured":"Grigorieva, I.V., Mirczuk S., Gaynor K.U., Nesbit M.A., Grigorieva E.F., Wei Q., Ali A., Fairclough R.J., Stacey J.M., Stechman M.J., Mihai R., Kurek D., Fraser W.D., Hough T., Condie B.G., Manley N., Grosveld F., Thakker R.V., Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2. J Clin Invest, 2010. 120(6): p. 2144\u20132155.","journal-title":"J Clin Invest"},{"issue":"1","key":"9527_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","volume":"38","author":"M Miettinen","year":"2014","unstructured":"Miettinen, M., McCue P.A., Sarlomo-Rikala M., Rys J., Czapiewski P., Wazny K., Langfort R., Waloszczyk P., Biernat W., Lasota J., Wang Z., GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol, 2014. 38(1): p. 13\u201322.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"9527_CR40","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten, J.D., Robbins C.M., Villablanca A., Forsberg L., Presciuttini S., Bailey-Wilson J., Simonds W.F., Gillanders E.M., Kennedy A.M., Chen J.D., Agarwal S.K., Sood R., Jones M.P., Moses T.Y., Haven C., Petillo D., Leotlela P.D., Harding B., Cameron D., Pannett A.A., H\u00f6\u00f6g A., Heath H., James-Newton L.A., Robinson B., Zarbo R.J., Cavaco B.M., Wassif W., Perrier N.D., Rosen I.B., Kristoffersson U., Turnpenny P.D., Farnebo L.O., Besser G.M., Jackson C.E., Morreau H., Trent J.M., Thakker R.V., Marx S.J., Teh B.T., Larsson C., Hobbs M.R., HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet, 2002. 32(4): p. 676\u2013680.","journal-title":"Nat Genet"},{"issue":"2","key":"9527_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1086\/302259","volume":"64","author":"MR Hobbs","year":"1999","unstructured":"Hobbs, M.R., Pole A.R., Pidwirny G.N., Rosen I.B., Zarbo R.J., Coon H., Heath III H., Leppert M., Jackson C.E., Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet, 1999. 64(2): p. 518\u2013525.","journal-title":"Am J Hum Genet"},{"key":"9527_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1159\/000345675","volume":"41","author":"GN Hendy","year":"2013","unstructured":"Hendy, G.N. and D.E. Cole, Genetic defects associated with familial and sporadic hyperparathyroidism. Front Horm Res, 2013. 41: p. 149\u2013165.","journal-title":"Front Horm Res"},{"issue":"6","key":"9527_CR43","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.surg.2007.09.029","volume":"142","author":"M Iacobone","year":"2007","unstructured":"Iacobone, M., et al., Parafibromin expression, single-gland involvement, and limited parathyroidectomy in familial isolated hyperparathyroidism. Surgery, 2007. 142(6): p. 984\u2013991; discussion 984\u201391.","journal-title":"Surgery"},{"issue":"1","key":"9527_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"WF Simonds","year":"2004","unstructured":"Simonds, W.F., Robbins C.M., Agarwal S.K., Hendy G.N., Carpten J.D., Marx S.J., Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab, 2004. 89(1): p. 96\u2013102.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9527_CR45","first-page":"2114","volume":"83","author":"BT Teh","year":"1998","unstructured":"Teh, B.T., Farnebo F., Twigg S., H\u00f6\u00f6g A., Kyt\u00f6l\u00e4 S., Korpi-Hy\u00f6v\u00e4lti E., Wong F.K., Nordenstr\u00f6m J., Grimelius L., Sandelin K., Robinson B., Farnebo L.O., Larsson C., Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab, 1998. 83(6): p. 2114\u20132120.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9527_CR46","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1359\/jbmr.060702","volume":"21","author":"TG Kelly","year":"2006","unstructured":"Kelly, T.G., Shattuck T.M., Reyes-Mugica M., Stewart A.F., Simonds W.F., Udelsman R., Arnold A., Carpenter T.O., Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res, 2006. 21(10): p. 1666\u20131671.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"9527_CR47","first-page":"944","volume":"56","author":"J Szabo","year":"1995","unstructured":"Szabo, J., et al., Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. Am J Hum Genet, 1995. 56(4): p. 944\u2013950.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"9527_CR48","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1128\/MCB.25.12.5052-5060.2005","volume":"25","author":"A Yart","year":"2005","unstructured":"Yart, A., Gstaiger M., Wirbelauer C., Pecnik M., Anastasiou D., Hess D., Krek W., The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol, 2005. 25(12): p. 5052\u20135060.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"9527_CR49","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard, G.E., Lin L., Zhang J.H., Agarwal S.K., Marx S.J., Simonds W.F., Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene, 2005. 24(7): p. 1272\u20131276.","journal-title":"Oncogene"},{"issue":"2","key":"9527_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen, O., Hughes C.M., Nannepaga S.J., Shanmugam K.S., Copeland T.D., Guszczynski T., Resau J.H., Meyerson M., The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol, 2005. 25(2): p. 612\u2013620.","journal-title":"Mol Cell Biol"},{"issue":"18","key":"9527_CR51","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck, T.M., V\u00e4lim\u00e4ki S., Obara T., Gaz R.D., Clark O.H., Shoback D., Wierman M.E., Tojo K., Robbins C.M., Carpten J.D., Farnebo L.O., Larsson C., Arnold A., Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med, 2003. 349(18): p. 1722\u20131729.","journal-title":"N Engl J Med"},{"issue":"9","key":"9527_CR52","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1210\/jc.2005-0717","volume":"90","author":"LJ Krebs","year":"2005","unstructured":"Krebs, L.J., T.M. Shattuck, and A. Arnold, HRPT2 mutational analysis of typical sporadic parathyroid adenomas. J Clin Endocrinol Metab, 2005. 90(9): p. 5015\u20135017.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9527_CR53","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1210\/jc.2004-0294","volume":"89","author":"F Cetani","year":"2004","unstructured":"Cetani, F., Pardi E., Borsari S., Viacava P., Dipollina G., Cianferotti L., Ambrogini E., Gazzerro E., Colussi G., Berti P., Miccoli P., Pinchera A., Marcocci C., Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab, 2004. 89(11): p. 5583\u20135591.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"9527_CR54","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1158\/1078-0432.CCR-04-0493","volume":"10","author":"MH Tan","year":"2004","unstructured":"Tan, M.H., Morrison C., Wang P., Yang X., Haven C.J., Zhang C., Zhao P., Tretiakova M.S., Korpi-Hyovalti E., Burgess J.R., Soo K.C., Cheah W.K., Cao B., Resau J., Morreau H., Teh B.T., Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res, 2004. 10(19): p. 6629\u20136637.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"9527_CR55","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/01.pas.0000209827.39477.4f","volume":"30","author":"AJ Gill","year":"2006","unstructured":"Gill, A.J., Clarkson A., Gimm O., Keil J., Dralle H., Howell V.M., Marsh D.J., Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol, 2006. 30(9): p. 1140\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"9527_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1677\/ERC-07-0021","volume":"14","author":"CC Juhlin","year":"2007","unstructured":"Juhlin, C.C., Villablanca A., Sandelin K., Haglund F., Nordenstrom J., Forsberg L., Branstrom R., Obara T., Arnold A., Larsson C., Hoog A., Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification. Endocr Relat Cancer, 2007. 14(2): p. 501\u2013512.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"9527_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1530\/EJE-06-0720","volume":"156","author":"F Cetani","year":"2007","unstructured":"Cetani, F., Ambrogini E., Viacava P., Pardi E., Fanelli G., Naccarato A.G., Borsari S., Lemmi M., Berti P., Miccoli P., Pinchera A., Marcocci C., Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol, 2007. 156(5): p. 547\u2013554.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9527_CR58","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/cncr.24037","volume":"115","author":"GG Fernandez-Ranvier","year":"2009","unstructured":"Fernandez-Ranvier, G.G., Khanafshar E., Tacha D., Wong M., Kebebew E., Duh Q.Y., Clark O.H., Defining a molecular phenotype for benign and malignant parathyroid tumors. Cancer, 2009. 115(2): p. 334\u2013344.","journal-title":"Cancer"},{"issue":"3","key":"9527_CR59","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12022-010-9121-z","volume":"21","author":"CC Juhlin","year":"2010","unstructured":"Juhlin, C.C., Nilsson I.L., Johansson K., Haglund F., Villablanca A., H\u00f6\u00f6g A., Larsson C., Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas. Endocr Pathol, 2010. 21(3): p. 166\u2013177.","journal-title":"Endocr Pathol"},{"issue":"2","key":"9527_CR60","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/hed.21716","volume":"34","author":"HK Kim","year":"2012","unstructured":"Kim, H.K., Oh Y.L., Kim S.H., Lee D.Y., Kang H.C., Lee J.I., Jang H.W., Hur K.Y., Kim J.H., Min Y.K., Chung J.H., Kim S.W., Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma. Head Neck, 2012. 34(2): p. 201\u2013206.","journal-title":"Head Neck"},{"issue":"6","key":"9527_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s13402-012-0100-x","volume":"35","author":"V Guarnieri","year":"2012","unstructured":"Guarnieri, V., Battista C., Muscarella L.A., Bisceglia M., de Martino D., Baorda F., Maiello E., D\u2019Agruma L., Chiodini I., Clemente C., Minisola S., Romagnoli E., Corbetta S., Viti R., Eller-Vainicher C., Spada A., Iacobellis M., Malavolta N., Carella M., Canaff L., Hendy G.N., Cole D.E.C., Scillitani A., CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohort. Cell Oncol (Dordr), 2012. 35(6): p. 411\u2013422.","journal-title":"Cell Oncol (Dordr)"},{"issue":"16","key":"9527_CR62","first-page":"2895","volume":"125","author":"O Wang","year":"2012","unstructured":"Wang, O., Wang C.Y., Shi J., Nie M., Xia W.B., Li M., Jiang Y., Guan H., Meng X.W., Xing X.P., Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors. Chin Med J (Engl), 2012. 125(16): p. 2895\u20132901.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"9527_CR63","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s00268-014-2700-2","volume":"38","author":"PP Truran","year":"2014","unstructured":"Truran, P.P., Johnson S.J., Bliss R.D., Lennard T.W.J., Aspinall S.R., Parafibromin, galectin-3, PGP9.5, Ki67, and cyclin D1: using an immunohistochemical panel to aid in the diagnosis of parathyroid cancer. World J Surg, 2014. 38(11): p. 2845\u20132854.","journal-title":"World J Surg"},{"issue":"6","key":"9527_CR64","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5001\/omj.2015.84","volume":"30","author":"S Karaarslan","year":"2015","unstructured":"Karaarslan, S., Yurum F.N., Kumbaraci B.S., Pala E.E., Sivrikoz O.N., Akyildiz M., Bugdayci M.H., The Role of Parafibromin, Galectin-3, HBME-1, and Ki-67 in the Differential Diagnosis of Parathyroid Tumors. Oman Med J, 2015. 30(6): p. 421\u2013427.","journal-title":"Oman Med J"},{"issue":"7","key":"9527_CR65","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/0284186X.2017.1306103","volume":"56","author":"EM Ryhanen","year":"2017","unstructured":"Ryhanen, E.M., et al., A nationwide study on parathyroid carcinoma. Acta Oncol, 2017. 56(7): p. 991\u20131003.","journal-title":"Acta Oncol"},{"issue":"4","key":"9527_CR66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1530\/EC-13-0046","volume":"2","author":"F Cetani","year":"2013","unstructured":"Cetani, F., Banti C., Pardi E., Borsari S., Viacava P., Miccoli P., Torregrossa L., Basolo F., Pelizzo M.R., Rugge M., Pennelli G., Gasparri G., Papotti M., Volante M., Vignali E., Saponaro F., Marcocci C., CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr Connect, 2013. 2(4): p. 186\u2013195.","journal-title":"Endocr Connect"},{"issue":"2","key":"9527_CR67","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell, V.M., Gill A., Clarkson A., Nelson A.E., Dunne R., Delbridge L.W., Robinson B.G., Teh B.T., Gimm O., Marsh D.J., Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab, 2009. 94(2): p. 434\u2013441.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"9527_CR68","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jmg.40.9.657","volume":"40","author":"VM Howell","year":"2003","unstructured":"Howell, V.M., Haven C.J., Kahnoski K., Khoo S.K., Petillo D., Chen J., Fleuren G.J., Robinson B.G., Delbridge L.W., Philips J., Nelson A.E., Krause U., Hammje K., Dralle H., Hoang-Vu C., Gimm O., Marsh D.J., Morreau H., Teh B.T., HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet, 2003. 40(9): p. 657\u2013663.","journal-title":"J Med Genet"},{"issue":"2","key":"9527_CR69","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1677\/erc.1.01058","volume":"13","author":"C Juhlin","year":"2006","unstructured":"Juhlin, C., Larsson C., Yakoleva T., Leibiger I., Leibiger B., Alimov A., Weber G., H\u00f6\u00f6g A., Villablanca A., Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr Relat Cancer, 2006. 13(2): p. 509\u2013523.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"9527_CR70","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s12020-016-0997-3","volume":"54","author":"Y Hu","year":"2016","unstructured":"Hu, Y., Liao Q., Cao S., Gao X., Zhao Y., Diagnostic performance of parafibromin immunohistochemical staining for sporadic parathyroid carcinoma: a meta-analysis. Endocrine, 2016. 54(3): p. 612\u2013619.","journal-title":"Endocrine"},{"issue":"5","key":"9527_CR71","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00268-007-9458-8","volume":"32","author":"Y Tominaga","year":"2008","unstructured":"Tominaga, Y., Tsuzuki T., Matsuoka S., Uno N., Sato T., Shimabukuro S., Goto N., Nagasaka T., Uchida K., Expression of parafibromin in distant metastatic parathyroid tumors in patients with advanced secondary hyperparathyroidism due to chronic kidney disease. World J Surg, 2008. 32(5): p. 815\u2013821.","journal-title":"World J Surg"},{"issue":"26","key":"9527_CR72","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1016\/j.febslet.2007.09.050","volume":"581","author":"MA Hahn","year":"2007","unstructured":"Hahn, M.A. and D.J. Marsh, Nucleolar localization of parafibromin is mediated by three nucleolar localization signals. FEBS Lett, 2007. 581(26): p. 5070\u20135074.","journal-title":"FEBS Lett"},{"issue":"2","key":"9527_CR73","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1677\/ERC-09-0272","volume":"17","author":"LM Panicker","year":"2010","unstructured":"Panicker, L.M., Zhang J.H., Dagur P.K., Gastinger M.J., Simonds W.F., Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr Relat Cancer, 2010. 17(2): p. 513\u2013524.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"9527_CR74","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00428-010-1032-3","volume":"459","author":"CC Juhlin","year":"2011","unstructured":"Juhlin, C.C., Haglund F., Obara T., Arnold A., Larsson C., H\u00f6\u00f6g A., Absence of nucleolar parafibromin immunoreactivity in subsets of parathyroid malignant tumours. Virchows Arch, 2011. 459(1): p. 47\u201353.","journal-title":"Virchows Arch"},{"issue":"2","key":"9527_CR75","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","volume":"27","author":"N Kumari","year":"2016","unstructured":"Kumari, N., Chaudhary N., Pradhan R., Agarwal A., Krishnani N., Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms. Endocr Pathol, 2016. 27(2): p. 87\u201396.","journal-title":"Endocr Pathol"},{"issue":"8","key":"9527_CR76","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.humpath.2005.06.020","volume":"36","author":"N Bergero","year":"2005","unstructured":"Bergero, N., de Pompa R., Sacerdote C., Gasparri G., Volante M., Bussolati G., Papotti M., Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases. Hum Pathol, 2005. 36(8): p. 908\u2013914.","journal-title":"Hum Pathol"},{"issue":"7","key":"9527_CR77","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00423-015-1361-4","volume":"401","author":"A Ozolins","year":"2016","unstructured":"Ozolins, A., Narbuts Z., Vanags A., Simtniece Z., Visnevska Z., Akca A., Wirowski D., Gardovskis J., Strumfa I., Goretzki P.E., Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism. Langenbecks Arch Surg, 2016. 401(7): p. 943\u2013951.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"9527_CR78","first-page":"562","volume":"20","author":"Z Inic","year":"2015","unstructured":"Inic, Z., Inic M., Jancic S., Paunovic I., Tatic S., Tausanovic K., Zivavljevic V., Zegarac M., Inic I., Dunjdjerovic D., The relationship between proliferation activity and parathyroid hormone levels in parathyroid tumors. J BUON, 2015. 20(2): p. 562\u2013566.","journal-title":"J BUON"},{"issue":"2A","key":"9527_CR79","first-page":"1305","volume":"26","author":"F Lumachi","year":"2006","unstructured":"Lumachi, F., Ermani M., Marino F., Iacobone M., Baldessin M., Cappuzzo G., Zanella S., Favia G., PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Anticancer Res, 2006. 26(2A): p. 1305\u20131308.","journal-title":"Anticancer Res"},{"issue":"1","key":"9527_CR80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/path.1489","volume":"202","author":"CJ Haven","year":"2004","unstructured":"Haven, C.J., van Puijenbroek M., Karperien M., Fleuren G.J., Morreau H., Differential expression of the calcium sensing receptor and combined loss of chromosomes 1q and 11q in parathyroid carcinoma. J Pathol, 2004. 202(1): p. 86\u201394.","journal-title":"J Pathol"},{"issue":"1","key":"9527_CR81","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/hupa.2003.55","volume":"34","author":"A Stojadinovic","year":"2003","unstructured":"Stojadinovic, A., Hoos A., Nissan A., Dudas M.E., Cordon-Cardo C., Shaha A.R., Brennan M.F., Singh B., Ghossein R.A., Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis. Hum Pathol, 2003. 34(1): p. 54\u201364.","journal-title":"Hum Pathol"},{"issue":"4","key":"9527_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10434-000-0301-9","volume":"7","author":"K Kameyama","year":"2000","unstructured":"Kameyama, K., Takami H., Umemura S., Osamura Y.R., Wada N., Sugino K., Mimura T., Ito K., PCNA and Ki-67 as prognostic markers in human parathyroid carcinomas. Ann Surg Oncol, 2000. 7(4): p. 301\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"9527_CR83","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1159\/000189481","volume":"74","author":"P Dionisio","year":"1996","unstructured":"Dionisio, P., Stramignoni E., Passarino G., Pucci A., Valenti M., Berto I.M., Barbos P., Cadario A., Gasparri G., Bajardi P., Recurrent secondary hyperparathyroidism due to parathyroid carcinoma: usefulness of Ki-67 immunostaining in the diagnosis of a malignant parathyroid tumor. Nephron, 1996. 74(4): p. 720\u2013723.","journal-title":"Nephron"},{"issue":"4","key":"9527_CR84","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02738728","volume":"6","author":"RV Lloyd","year":"1995","unstructured":"Lloyd, R.V., Carney J.A., Ferreiro J.A., Jin L., Thompson G.B., van Heerden J.A., Grant C.S., Wollan P.C., Immunohistochemical Analysis of the Cell Cycle-Associated Antigens Ki-67 and Retinoblastoma Protein in Parathyroid Carcinomas and Adenomas. Endocr Pathol, 1995. 6(4): p. 279\u2013287.","journal-title":"Endocr Pathol"},{"key":"9527_CR85","doi-asserted-by":"crossref","unstructured":"Hosny Mohammed, K., et al., Parafibromin, APC, and MIB-1 Are Useful Markers for Distinguishing Parathyroid Carcinomas From Adenomas. Appl Immunohistochem Mol Morphol, 2016.","DOI":"10.1097\/PAI.0000000000000378"},{"issue":"1","key":"9527_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1309\/9NXP7FRF87MU2PCK","volume":"126","author":"E Saggiorato","year":"2006","unstructured":"Saggiorato, E., Bergero N., Volante M., Bacillo E., Rosas R., Gasparri G., Orlandi F., Papotti M., Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J Clin Pathol, 2006. 126(1): p. 59\u201366.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"9527_CR87","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1245\/s10434-013-3288-8","volume":"21","author":"S Kruijff","year":"2014","unstructured":"Kruijff, S., Sidhu S.B., Sywak M.S., Gill A.J., Delbridge L.W., Negative parafibromin staining predicts malignant behavior in atypical parathyroid adenomas. Ann Surg Oncol, 2014. 21(2): p. 426\u2013433.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"9527_CR88","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/00000478-200405000-00003","volume":"28","author":"LA Erickson","year":"2004","unstructured":"Erickson, L.A., Jalal S.M., Harwood A., Shearer B., Jin L., Lloyd R.V., Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization. Am J Surg Pathol, 2004. 28(5): p. 578\u2013584.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"9527_CR89","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0002-9440(10)64086-2","volume":"158","author":"S Hemmer","year":"2001","unstructured":"Hemmer, S., Wasenius V.M., Haglund C., Zhu Y., Knuutila S., Franssila K., Joensuu H., Deletion of 11q23 and cyclin D1 overexpression are frequent aberrations in parathyroid adenomas. Am J Pathol, 2001. 158(4): p. 1355\u20131362.","journal-title":"Am J Pathol"},{"issue":"4","key":"9527_CR90","first-page":"412","volume":"12","author":"MA Vasef","year":"1999","unstructured":"Vasef, M.A., Brynes R.K., Sturm M., Bromley C., Robinson R.A., Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study. Mod Pathol, 1999. 12(4): p. 412\u2013416.","journal-title":"Mod Pathol"},{"issue":"5","key":"9527_CR91","first-page":"1736","volume":"81","author":"ED Hsi","year":"1996","unstructured":"Hsi, E.D., Zukerberg L.R., Yang W.I., Arnold A., Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab, 1996. 81(5): p. 1736\u20131739.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9527_CR92","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12022-012-9222-y","volume":"23","author":"BM Erovic","year":"2012","unstructured":"Erovic, B.M., Harris L., Jamali M., Goldstein D.P., Irish J.C., Asa S.L., Mete O., Biomarkers of parathyroid carcinoma. Endocr Pathol, 2012. 23(4): p. 221\u2013231.","journal-title":"Endocr Pathol"},{"issue":"3","key":"9527_CR93","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12253-011-9483-7","volume":"18","author":"K Arvai","year":"2012","unstructured":"Arvai, K., et al., Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma. Pathol Oncol Res, 2012. 18(3): p. 607\u2013614.","journal-title":"Pathol Oncol Res"},{"issue":"6","key":"9527_CR94","first-page":"733","volume":"24","author":"N Osawa","year":"2009","unstructured":"Osawa, N., Onoda N., Kawajiri H., Tezuka K., Takashima T., Ishikawa T., Miyauchi A., Hirokawa M., Wakasa K., Hirakawa K., Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT. Int J Mol Med, 2009. 24(6): p. 733\u2013741.","journal-title":"Int J Mol Med"},{"issue":"9","key":"9527_CR95","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1210\/jcem.81.9.8784068","volume":"81","author":"C Dotzenrath","year":"1996","unstructured":"Dotzenrath, C., Teh B.T., Farnebo F., Cupisti K., Svensson A., Toell A., Goretzki P., Larsson C., Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? J Clin Endocrinol Metab, 1996. 81(9): p. 3194\u20133196.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9527_CR96","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM199403173301105","volume":"330","author":"VL Cryns","year":"1994","unstructured":"Cryns, V.L., Thor A., Xu H.J., Hu S.X., Wierman M.E., Vickery Jr A.L., Benedict W.F., Arnold A., Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med, 1994. 330(11): p. 757\u2013761.","journal-title":"N Engl J Med"},{"issue":"2","key":"9527_CR97","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1365-2265.2003.01814.x","volume":"59","author":"TM Shattuck","year":"2003","unstructured":"Shattuck, T.M., Kim T.S., Costa J., Yandell D.W., Imanishi Y., Palanisamy N., Gaz R.D., Shoback D., Clark O.H., Monchik J.M., Wierman M.E., Hollenberg A., Tojo K., Chaganti R.S.K., Arnold A., Mutational analyses of RB and BRCA2 as candidate tumour suppressor genes in parathyroid carcinoma. Clin Endocrinol (Oxf), 2003. 59(2): p. 180\u2013189.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"9527_CR98","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/j.1445-2197.1995.tb00542.x","volume":"65","author":"P Subramaniam","year":"1995","unstructured":"Subramaniam, P., S. Wilkinson, and J.J. Shepherd, Inactivation of retinoblastoma gene in malignant parathyroid growths: a candidate genetic trigger? Aust N Z J Surg, 1995. 65(10): p. 714\u2013716.","journal-title":"Aust N Z J Surg"},{"issue":"3","key":"9527_CR99","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00000478-199903000-00007","volume":"23","author":"LA Erickson","year":"1999","unstructured":"Erickson, L.A., Jin L., Wollan P., Thompson G.B., van Heerden J.A., Lloyd R.V., Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein. Am J Surg Pathol, 1999. 23(3): p. 288\u2013295.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"9527_CR100","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/modpathol.2010.236","volume":"24","author":"JE Witteveen","year":"2011","unstructured":"Witteveen, J.E., Hamdy N.A.T., Dekkers O.M., Kievit J., van Wezel T., Teh B.T., Romijn J.A., Morreau H., Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod Pathol, 2011. 24(5): p. 688\u2013697.","journal-title":"Mod Pathol"},{"issue":"3","key":"9527_CR101","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mpdhp.2016.02.003","volume":"22","author":"K Duan","year":"2016","unstructured":"Duan, K., Mete, O., Familial Hyperparathyroidism Syndromes. Diagnostic Histopathology, 2016. 22(3): p. 92\u2013100.","journal-title":"Diagnostic Histopathology"},{"key":"9527_CR102","doi-asserted-by":"crossref","unstructured":"Gill, A.J., Lim G., Cheung V.K.Y., Andrici J., Perry-Keene J.L., Paik J., Sioson L., Clarkson A., Sheen A., Luxford C., Elston M.S., Meyer-Rochow G.Y., Nano M.T., Kruijff S., Engelsman A.F., Sywak M., Sidhu S.B., Delbridge L.W., Robinson B.G., Marsh D.J., Toon C.W., Chou A., Clifton-Bligh R.J., Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features. Am J Surg Pathol, 2018, 1.","DOI":"10.1097\/PAS.0000000000001017"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-018-9527-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-018-9527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-018-9527-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T04:55:57Z","timestamp":1660971357000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-018-9527-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,7]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9527"],"URL":"https:\/\/doi.org\/10.1007\/s12022-018-9527-6","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,7]]},"assertion":[{"value":"7 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}